349 related articles for article (PubMed ID: 26880993)
1. Induced Pluripotent Stem Cells: Generation Strategy and Epigenetic Mystery behind Reprogramming.
Ji P; Manupipatpong S; Xie N; Li Y
Stem Cells Int; 2016; 2016():8415010. PubMed ID: 26880993
[TBL] [Abstract][Full Text] [Related]
2. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery.
Singh VK; Kalsan M; Kumar N; Saini A; Chandra R
Front Cell Dev Biol; 2015; 3():2. PubMed ID: 25699255
[TBL] [Abstract][Full Text] [Related]
3. Identification of the early and late responder genes during the generation of induced pluripotent stem cells from mouse fibroblasts.
Park J; Kwon YW; Ham S; Hong CP; Seo S; Choe MK; Shin SI; Lee CS; Kim HS; Roh TY
PLoS One; 2017; 12(2):e0171300. PubMed ID: 28152015
[TBL] [Abstract][Full Text] [Related]
4. Cellular reprogramming in farm animals: an overview of iPSC generation in the mammalian farm animal species.
Ogorevc J; Orehek S; Dovč P
J Anim Sci Biotechnol; 2016; 7():10. PubMed ID: 26900466
[TBL] [Abstract][Full Text] [Related]
5. Generation of induced pluripotent stem cells from somatic cells.
Sohn YD; Han JW; Yoon YS
Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
[TBL] [Abstract][Full Text] [Related]
6. Ten years of progress and promise of induced pluripotent stem cells: historical origins, characteristics, mechanisms, limitations, and potential applications.
Omole AE; Fakoya AOJ
PeerJ; 2018; 6():e4370. PubMed ID: 29770269
[TBL] [Abstract][Full Text] [Related]
7. The miR-302-Mediated Induction of Pluripotent Stem Cells (iPSC): Multiple Synergistic Reprogramming Mechanisms.
Ying SY; Fang W; Lin SL
Methods Mol Biol; 2018; 1733():283-304. PubMed ID: 29435941
[TBL] [Abstract][Full Text] [Related]
8. Current status of induced pluripotent stem cells in cardiac tissue regeneration and engineering.
Liu Z; Zhou J; Wang H; Zhao M; Wang C
Regen Med Res; 2013 Dec; 1(1):6. PubMed ID: 25984325
[TBL] [Abstract][Full Text] [Related]
9. Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.
Löhle M; Hermann A; Glass H; Kempe A; Schwarz SC; Kim JB; Poulet C; Ravens U; Schwarz J; Schöler HR; Storch A
Stem Cells; 2012 Mar; 30(3):570-9. PubMed ID: 22213586
[TBL] [Abstract][Full Text] [Related]
10. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
Quintana-Bustamante O; Segovia JC
Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
[TBL] [Abstract][Full Text] [Related]
11. Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling.
Beghini DG; Kasai-Brunswick TH; Henriques-Pons A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397069
[TBL] [Abstract][Full Text] [Related]
12. The role of the reprogramming method and pluripotency state in gamete differentiation from patient-specific human pluripotent stem cells.
Mishra S; Kacin E; Stamatiadis P; Franck S; Van der Jeught M; Mertes H; Pennings G; De Sutter P; Sermon K; Heindryckx B; Geens M
Mol Hum Reprod; 2018 Apr; 24(4):173-184. PubMed ID: 29471503
[TBL] [Abstract][Full Text] [Related]
13. Pluripotent stem cell for modeling neurological diseases.
Yung JS; Tam PK; Ngan ES
Exp Cell Res; 2013 Jan; 319(2):177-84. PubMed ID: 23159386
[TBL] [Abstract][Full Text] [Related]
14. Modulation of embryonic stem cell fate and somatic cell reprogramming by small molecules.
Zhang XZ
Reprod Biomed Online; 2010 Jul; 21(1):26-36. PubMed ID: 20462797
[TBL] [Abstract][Full Text] [Related]
15. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases.
Hung SSC; Khan S; Lo CY; Hewitt AW; Wong RCB
Pharmacol Ther; 2017 Sep; 177():32-43. PubMed ID: 28223228
[TBL] [Abstract][Full Text] [Related]
16. Pluripotent Stem Cell Therapy in Ischemic Cardiovascular Disease.
Chao TH; Chen IC; Tseng SY; Li YH
Acta Cardiol Sin; 2014 Sep; 30(5):365-74. PubMed ID: 27122813
[TBL] [Abstract][Full Text] [Related]
17. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
Yoshida Y; Yamanaka S
Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
[TBL] [Abstract][Full Text] [Related]
18. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
[TBL] [Abstract][Full Text] [Related]
19. Generation of Induced Pluripotent Stem Cells with Substitutes for Yamanaka's Four Transcription Factors.
Xiao X; Li N; Zhang D; Yang B; Guo H; Li Y
Cell Reprogram; 2016 Oct; 18(5):281-297. PubMed ID: 27696909
[TBL] [Abstract][Full Text] [Related]
20. Generation of porcine-induced pluripotent stem cells by using OCT4 and KLF4 porcine factors.
Liu K; Ji G; Mao J; Liu M; Wang L; Chen C; Liu L
Cell Reprogram; 2012 Dec; 14(6):505-13. PubMed ID: 23035653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
